These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14227806)

  • 1. TREATMENT OF PULMONARY TUBERCULOSIS BY CAPREOMYCIN AND PAS: A SMALL PRELIMINARY TRIAL.
    CUTHBERT J; BRUCE LG
    Tubercle; 1964 Sep; 45():205-10. PubMed ID: 14227806
    [No Abstract]   [Full Text] [Related]  

  • 2. [1-YEAR RESULTS OF ANTIBACTERIAL THERAPY OF RECENTLY DISCOVERED CAVERNOUS PULMONARY TUBERCULOSIS].
    ZIERSKI M; BEK E; SIWINSKA I; WOZNIAK S
    Gruzlica (1926); 1964 Feb; 32():97-105. PubMed ID: 14136693
    [No Abstract]   [Full Text] [Related]  

  • 3. A CONTROLLED TRIAL OF ISONIAZID AND 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE COMPARED WITH ISONIAZID AND PAS AND ISONIAZID, STREPTOMYCIN AND PAS.
    OLEJNICEK M; WEBEROVA M; NOVAK M; JANCIK E
    Tubercle; 1965 Jun; 46():188-92. PubMed ID: 14327966
    [No Abstract]   [Full Text] [Related]  

  • 4. SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
    NOVAK M; JANCIK E
    Acta Tuberc Pneumol Scand; 1964; 45():301-19. PubMed ID: 14234473
    [No Abstract]   [Full Text] [Related]  

  • 5. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.
    MITCHISON DA
    Br Med J; 1965 May; 1(5446):1333-40. PubMed ID: 14278838
    [No Abstract]   [Full Text] [Related]  

  • 6. TREATMENT OF PATIENTS WITH CULTURES RESISTANT TO THE PRIMARY ANTI-TUBERCULOSIS DRUGS.
    ZIERSKI M
    Tubercle; 1964 Jun; 45():96-100. PubMed ID: 14161919
    [No Abstract]   [Full Text] [Related]  

  • 7. A CONTROLLED COMPARISON OF STREPTOMYCIN PLUS PYRAZINAMIDE AND STREPTOMYCIN PLUS PAS IN THE RETREATMENT OF PATIENTS EXCRETING ISONIAZID-RESISTANT ORGANISMS.
    VELU S; DAWSON JJ; DEVADATTA S; FOX W; KULKARNI KG; MOHAN K; RAMAKRISHNAN CV; STOTT H
    Tubercle; 1964 Jun; 45():144-59. PubMed ID: 14161913
    [No Abstract]   [Full Text] [Related]  

  • 8. [CLINICAL MEDITATIONS ON "BACTERIAL RESISTANCE" IN CHEMO-ANTIBIOTIC THERAPY OF PULMONARY TUBERCULOSIS].
    CAFIERO F
    Minerva Med; 1964 Sep; 55():2795-800. PubMed ID: 14199467
    [No Abstract]   [Full Text] [Related]  

  • 9. [PREVENTION OF DRUG RESISTANCE FREQUENTLY OCCURRING IN AGED TUBERCULOSIS PATIENTS].
    SERI I
    Tuberk Tudobetegsegek; 1963 Aug; 16():252-4. PubMed ID: 14085670
    [No Abstract]   [Full Text] [Related]  

  • 10. [On results of examination of drug resistant tubercle bacilli in the sputum before chemotherapy of tuberculosis. 2].
    NAITO M
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1962 Sep; 11():38-43. PubMed ID: 13937293
    [No Abstract]   [Full Text] [Related]  

  • 11. THE CLINICAL SIGNIFICANCE OF LOW DEGREES OF DRUG RESISTANCE IN PULMONARY TUBERCULOSIS.
    STEWART SM; CROFTON JW
    Am Rev Respir Dis; 1964 Jun; 89():811-29. PubMed ID: 14169411
    [No Abstract]   [Full Text] [Related]  

  • 12. A PRELIMINARY REPORT ON A NEW ANTITUBERCULOUS DRUG 4-AMINO-2-HYDROXY-PHENYL-1, 3, 4,-OXADIAZOL-2-OL WS 127.
    SMITH AE; ASPEVIK E; EVENSTAD E; HAUKENES G
    Acta Tuberc Pneumol Scand; 1964; 45():231-55. PubMed ID: 14234467
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE PROBLEM OF PRIMARY RESISTANCE].
    KATONA L; LAKITS E; PALOS F
    Tuberk Tudobetegsegek; 1964 Apr; 17():111-4. PubMed ID: 14186511
    [No Abstract]   [Full Text] [Related]  

  • 14. CHEMOTHERAPY OF PULMONARY TUBERCULOSIS IN ADULTS: THE CHOICE OF DRUGS IN RELATION TO DRUG SUSCEPTIBILITY. A STATEMENT OF THE COMMITTEE ON THERAPY.
    TSUKAMURA M
    Am Rev Respir Dis; 1965 Sep; 92():508-12. PubMed ID: 14346379
    [No Abstract]   [Full Text] [Related]  

  • 15. [1-YEAR RESULTS OF ANTIBACTERIAL THERAPY OF RECENTLY DISCOVERED CAVERNOUS PULMONARY TUBERCULOSIS].
    ZAJACZKOWSKA J; JANCZY S; BURACZEWSKA M; KORLAKOWSKI J; ZYCH D; KRYCHNIAK W
    Gruzlica (1926); 1964 Feb; 32():89-95. PubMed ID: 14136692
    [No Abstract]   [Full Text] [Related]  

  • 16. THE PROBLEM AND MANAGEMENT OF DRUG-RESISTANT CASES OF PULMONARY TUBERCULOSIS IN KENYA.
    ANGAWA JO
    East Afr Med J; 1964 Sep; 41():436-40. PubMed ID: 14229818
    [No Abstract]   [Full Text] [Related]  

  • 17. CONTROLLED CLINICAL TRIAL OF 4-4 DIISOAMYLOXYTHIOCARBANILIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
    MOODIE AS; SISTER AQUINAS ; FOORD RD
    Tubercle; 1964 Sep; 45():192-201. PubMed ID: 14227804
    [No Abstract]   [Full Text] [Related]  

  • 18. CHEMOTHERAPY OF PREVIOUSLY TREATED PATIENTS WITH PULMONARY TUBERCULOSIS.
    GIUNIO N
    Tubercle; 1964 Sep; 45():202-4. PubMed ID: 14227805
    [No Abstract]   [Full Text] [Related]  

  • 19. [ANTIMICROBIAL SCREEN IN PHTHISIOLOGICAL SURGERY].
    SNAJDR V; KRAKORA P; FISER F; CHODOUNSKA V
    Rozhl Chir; 1963 Oct; 42():712-20. PubMed ID: 14119837
    [No Abstract]   [Full Text] [Related]  

  • 20. [ACTION ON MYCOBACTERIUM TUBERCULOSIS OF CAPREOMYCIN IN VITRO, ALONE OR COMBINED WITH STREPTOMYCIN, INH (ISONICOTINIC HYDRAZIDE) OR PAS (PARA-AMINOSALICYLIC ACID)].
    COLETSOS P
    C R Hebd Seances Acad Sci; 1964 Apr; 258():3936-7. PubMed ID: 14145409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.